The discovery of a new downstream target for the Ras GTPases -a Nore1-Mst1 protein complexreveals a mechanism by which Ras can promote apoptosis, and suggests that the influence of Ras on cell survival or death depends upon the relative level of activation of its various target proteins. 
PI 3-kinase can also suppress apoptosis through activation of the Rac GTPase, possibly through activation of NF-κ κB [4] . Thus, the activation of PI 3-kinase associated with excessive Ras activity may promote oncogenesis by blunting the apoptosis-inducing stimuli associated with oncogenic transformation.
A set of papers, the latest of which is by Khokhlatchev et al. [5] in a recent issue of Current Biology, has now provided strong support for the existence of yet another Ras effector pathway influencing cell survival. This one has the opposite effect of PI 3-kinase in that it promotes apoptosis. As such, it may suppress Ras-induced oncogenesis by preventing transformed cells from surviving. This new signaling pathway is mediated by Ras binding to a complex of the Nore1 (novel Ras effector 1) and Mst1 (mammalian Ste20-like kinase) proteins. Nore1 was first identified as a protein with the ability to bind specifically to the active GTP-bound form of Ras [6] Nevertheless, a clue to Nore1 function is provided by the fact that it is most closely related to a family of proteins encoded by the alternative splicing of the putative tumor suppressor gene, RASSF1 (Ras association domain family). RNA transcripts of one of three alternatively spliced versions of RASSF1, RASSF1A, are missing in all small cell lung cancer cell lines tested [7] . RASSF1A and RASSF1C mRNAs are also missing in several other cancer cell lines [8] . Although Nore1 itself has not yet been implicated as a tumor suppressor gene product, it heterodimerizes with RASSF1A in cells, and thus it may influence tumor suppressor activity [9] .
Given the exciting genetic evidence for RASSF1 in human oncogenesis, understanding its biological function is obviously of interest. One clue has come from the observation that overexpression of RASSF1C can promote apoptosis [10] . The new paper by Khokhlatchev et al. [5] now shows that Nore1 also promotes apoptosis. In fact, these related proteins may induce apoptosis by a similar mechanism, since both RASSF1A and Nore1 bind to Mst1, a protein kinase already implicated in the process of apoptosis. Mst1 [11] is a Ste20-related member of the Group II GC kinases that also promotes apoptosis upon overexpression in cells [ What about life and death decisions in oncogenesis? The tumor suppressor, RASSF1, may participate in Ras-induced apoptosis either through heterodimer formation with the Ras-binding Nore1 protein or through its potential to bind directly to Ras [9] . If so, the loss of RASSF1 expression may promote oncogenesis by preventing Ras-induced apoptosis and thus tip the balance of Ras signaling in favor of the survival-promoting effects of the Ras-PI 3-kinase signaling cascade (Figure 2) . Interestingly, K-Ras, not H-Ras, is commonly activated by mutation in lung cancer [19] where RASSF1 expression is frequently absent. Could it be that loss of RASSF1 is particularly important in KRas-induced oncogenesis to overcome the relative inefficiency at which K-Ras activates the pro-survival PI 3-kinase pathway compared with the pro-apoptotic Nore1-Mst1 pathway? Perhaps RASSF1 expression should be investigated in pancreatic cancer, where K-Ras activation is also a common genetic event.
While these correlations are striking, contradictions do exist in the literature. For example, in a different study of Ras induction of apoptosis using rat embryo fibroblasts, comparison of the effectiveness of K-Ras and H-Ras in inducing apoptosis led to the opposite conclusion. K-Ras was less effective than H-Ras in 
